ISSN: 0268-3369

Journal Home

Journal Guideline

Bone Marrow Transplantation Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bone Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 144. It has a price of 3580 €. It has an SJR impact factor of 1,318 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,318.

Bone Marrow Transplantation focuses its scope in these topics and keywords: cell, stem, allogeneic, hematopoietic, transplantation, patients, blood, transplant, peripheral, conditioning, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Transplantation (Q1)

Price

3580 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,318

SJR Impact factor

144

H Index

266

Total Docs (Last Year)

1166

Total Docs (3 years)

6193

Total Refs

3032

Total Cites (3 years)

695

Citable Docs (3 years)

2.66

Cites/Doc (2 years)

23.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

Monitoring four herpesviruses in unrelated cord blood transplantation

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation

Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT

Phialophora verrucosa infection in a BMT patient

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients

SHOW MORE ARTICLES

Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature

Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

Neosartorya fischeri: an invasive fungal pathogen in an allogeneic bone marrow transplant patient

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

Antibody and pre- plus post-transplant prednisone treatments support T cell-depleted stem cell engraftment without drug-induced morbidity

Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant

Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT

Mucormycosis of the vulva following bone marrow transplantation

Acute pneumatosis cystoides intestinalis following allogeneic transplantation -the surgeon's dilemma

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies